Diabetic retinopathy Flashcards
Pathophysiology of diabetic retinopathy?
Hyperglycaemia is thought to cause increased retinal blood flow and abnormal metabolism in the retinal vessel walls.
precipitates damage to endothelial cells and pericytes
Endothelial dysfunction leads to increased vascular permeability which causes the characteristic exudates seen on fundoscopy
classification of diabetic retinopathy ?
Non-proliferative diabetic retinopathy
Proliferative diabetic retinopathy
Maculopathy
classification in Non-proliferative diabetic retinopathy?
Mild NPDR
Moderate NPDR
Severe NPDR
classification of mild NPDR?
1 or more microaneurysm
classification of moderate NPDR?
microaneurysms
blot haemorrhages
hard exudates
cotton wool spots (‘soft exudates’ - represent areas of retinal infarction),
venous beading/looping
intraretinal microvascular abnormalities (IRMA) less severe than in severe NPDR
classification of severe NPDR?
blot haemorrhages and microaneurysms in 4 quadrants
venous beading in at least 2 quadrants
IRMA in at least 1 quadrant
classification of Proliferative diabetic retinopathy
retinal neovascularisation - may lead to vitrous haemorrhage
fibrous tissue forming anterior to retinal disc
Proliferative diabetic retinopathy more common in ?
more common in Type I DM, 50% blind in 5 years
Maculopathy more common in ?
Type II DM
Maculopathy based on ?
location rather than severity
features of maculopthy ?
hard exudates and other ‘background’ changes on macula
check visual acuity
managemt of all diabetic retinopathy ?
optimise glycaemic control, blood pressure and hyperlipidemia
regular review by ophthalmology
managemt of diabetic maculopathy ?
change in visual acuity then intravitreal vascular endothelial growth factor (VEGF) inhibitors
mx of Non-proliferative retinopathy
regular observation
if severe/very severe consider panretinal laser photocoagulation
mx of proliferative retinopathy
panretinal laser photocoagulation
intravitreal VEGF inhibitors - now used in combination with panretinal laser photocoagulation
examples include ranibizumab
slow progression of proliferative diabetic retinopathy and improve visual acuity